Sandro Vento

7.1k total citations · 1 hit paper
127 papers, 3.6k citations indexed

About

Sandro Vento is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Sandro Vento has authored 127 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Epidemiology, 42 papers in Infectious Diseases and 42 papers in Hepatology. Recurrent topics in Sandro Vento's work include Liver Disease Diagnosis and Treatment (32 papers), Hepatitis B Virus Studies (22 papers) and HIV Research and Treatment (20 papers). Sandro Vento is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Hepatitis B Virus Studies (22 papers) and HIV Research and Treatment (20 papers). Sandro Vento collaborates with scholars based in Italy, Botswana and Cambodia. Sandro Vento's co-authors include Francesca Cainelli, Ercole Concia, Teresa Ferraro, Massimiliano Lanzafame, Tiziana Garofano, Carlo Renzini, Ferruccio Casali, Giancarlo Ghironzi, Zelalem Temesgen and A L Eddleston and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Sandro Vento

119 papers receiving 3.5k citations

Hit Papers

Fulminant Hepatitis Associated with Hepatitis A Virus Sup... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandro Vento Italy 31 1.9k 1.6k 738 406 341 127 3.6k
Chiara Azzari Italy 38 2.7k 1.4× 1.3k 0.8× 733 1.0× 367 0.9× 589 1.7× 251 5.1k
Claudia Vellozzi United States 41 2.7k 1.4× 1.2k 0.8× 1.4k 1.9× 415 1.0× 170 0.5× 91 4.4k
Jun Hayashi Japan 37 2.6k 1.4× 2.2k 1.4× 475 0.6× 479 1.2× 596 1.7× 215 4.5k
Nina Weis Denmark 29 1.6k 0.8× 1.3k 0.8× 663 0.9× 143 0.4× 326 1.0× 181 3.0k
William L. Irving United Kingdom 38 3.2k 1.7× 2.9k 1.9× 876 1.2× 208 0.5× 457 1.3× 209 5.1k
Bruno Cacopardo Italy 31 1.2k 0.7× 643 0.4× 779 1.1× 225 0.6× 208 0.6× 171 3.1k
George J. Nemo United States 30 1.9k 1.0× 1.3k 0.8× 1.2k 1.7× 369 0.9× 389 1.1× 50 4.7k
Deanna Kruszon-Moran United States 20 3.1k 1.7× 2.6k 1.6× 584 0.8× 190 0.5× 132 0.4× 29 4.3k
Víctor Asensi Spain 25 963 0.5× 604 0.4× 711 1.0× 288 0.7× 244 0.7× 128 2.3k
Kumar Visvanathan Australia 34 2.4k 1.3× 1.8k 1.1× 468 0.6× 271 0.7× 960 2.8× 124 3.8k

Countries citing papers authored by Sandro Vento

Since Specialization
Citations

This map shows the geographic impact of Sandro Vento's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Vento with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Vento more than expected).

Fields of papers citing papers by Sandro Vento

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandro Vento. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Vento. The network helps show where Sandro Vento may publish in the future.

Co-authorship network of co-authors of Sandro Vento

This figure shows the co-authorship network connecting the top 25 collaborators of Sandro Vento. A scholar is included among the top collaborators of Sandro Vento based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandro Vento. Sandro Vento is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vento, Sandro. (2025). Opinion: Medical education in many low- and middle-income countries needs urgent attention and serious improvement. Frontiers in Medicine. 12. 1548112–1548112. 1 indexed citations
2.
Kebede, Yohannes, Kannan Subbaram, Robert J. Edwards, et al.. (2024). Trends in publication and collaboration of health-themed systematic reviews before and during the COVID-19 pandemic: A bibliometric study. 2(1). e106–e106. 3 indexed citations
4.
Lanzafame, Massimiliano, et al.. (2023). Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV. AIDS Research and Human Retroviruses. 40(2). 69–72.
5.
Mudatsir, Mudatsir, Ichsan Ichsan, Mehrdad Amir‐Behghadami, et al.. (2022). Acceptance and willingness to purchase a hypothetical COVID-19 vaccine in a region under Shariah law: A cross-sectional study in Aceh, Indonesia. Narra J. 2(2). e85–e85. 5 indexed citations
6.
Lanzafame, Massimiliano, et al.. (2018). Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir.. PubMed. 41(4). 262–267. 3 indexed citations
7.
Cainelli, Francesca, et al.. (2017). Type 1 Gaucher disease with fatal outcome in a 17-year-old girl from Kazakhstan.. PubMed. 19(5). 329–330. 1 indexed citations
8.
Lanzafame, Massimiliano, et al.. (2014). Efavirenz dose reduction in HIV-infected patients. AIDS. 28(18). 2789–2790. 4 indexed citations
9.
Cainelli, Francesca, et al.. (2013). A case of severe hypokalemic myopathy due to clay ingestion.. PubMed. 15(9). 524–5. 1 indexed citations
10.
Vento, Sandro, Francesca Cainelli, & Zelalem Temesgen. (2008). Perspectives in therapy for hepatitis C. Expert Opinion on Investigational Drugs. 17(11). 1635–1639. 3 indexed citations
11.
Knoll, Bettina M., Sandro Vento, & Zelalem Temesgen. (2008). Etravirine. Drugs of today. 44(1). 23–23. 8 indexed citations
12.
Temesgen, Zelalem, et al.. (2006). Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults. The Lancet Infectious Diseases. 6(8). 496–507. 19 indexed citations
13.
Ferrari, Sérgio, Massimiliano Lanzafame, Federica Faggian, et al.. (2004). Painful Neuropathy Vasculitis in 2 Patients with Long-Standing Human Immunodeficiency Virus-1 Infection. Scandinavian Journal of Infectious Diseases. 36(5). 392–393. 5 indexed citations
14.
Trevenzoli, Marco, et al.. (2003). Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report.. PubMed. 11(1). 40–1. 1 indexed citations
15.
Vento, Sandro, et al.. (2002). How tainted is medicine? [1] (multiple letters). The Lancet. 359(9319). 1775–1776.
16.
Vento, Sandro. (2000). Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. Journal of Viral Hepatitis. 7(s1). 7–8. 45 indexed citations
17.
Bonora, Stefano, et al.. (1998). Failure of Prophylaxis against PCP in Patients with HIV Infection. AIDS Patient Care and STDs. 12(11). 843–848. 4 indexed citations
18.
Lanzafame, Massimiliano, Stefano Bonora, Giovanni Di Perri, et al.. (1997). Microsporidium Species in Pulmonary Cavity Lesions of AIDS Patient Infected withRhodococcus equi. Clinical Infectious Diseases. 25(4). 926–927. 7 indexed citations
19.
Cruciani, Mario, Elisa Bertazzoni Minelli, Massimo Mirandola, et al.. (1996). Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data. Clinical Microbiology and Infection. 2(1). 30–35. 3 indexed citations
20.
Castelli, Francesco, Rocco Micciolo, Angelo Cazzadori, et al.. (1993). Transmission of HIV-Associated Tuberculosis to Healthcare Workers. Infection Control and Hospital Epidemiology. 14(2). 67–72. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026